Genetic investigations consisting of array-CGH and overgrowth syndrome panel showed a duplication of 140 kb in Xq24, encompassing SLC25A43 and the 5′ terminal of CXorf56, considered as likely benign as duplications of these regions are found in the control population. This evidence concerns the gene SLC25A43 and overgrowth syndrome.